Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Imaging Diagnostic Systems, Inc., provider of laser optical breast imaging systems, has announced that the majority of international CTLM systems have been upgraded to the 4.1 Performance Package level, which includes several significant enhancements. Imaging Diagnostic Systems, Inc., provider of laser optical breast imaging systems, has announced that the majority of international CTLM systems have been upgraded to the 4.1 Performance Package level, which includes several significant enhancements.

According to Tim Hansen, Imaging Diagnostic Systems' Chief Executive Officer, "When we launched our US FDA Premarket Approval data collection study, we announced that many improvements had been made to the CTLM system since the prior study in 2001. We wanted our global users to share in these improvements as well; recent shipments from our factory have routinely included the 4.1 Package. Our plan has always been to upgrade the installed CTLM base as well." Continued Hansen, "We are now nearing completion of that field upgrade program, done entirely at IMDS expense, to ensure continued customer satisfaction and excellent CTLM system performance. The remaining upgrade sites include China and sites pending final installation. This upgrade to the highest performance level has been a major accomplishment for our organization and a source of great satisfaction for our users."

The 4.1 Package enhancements include: new scan control software to reduce scan time from 12 to nine minutes, increasing patient throughput by 25 per cent while adding to patient comfort and reducing patient movement artifacts; CTLM self- diagnostic background software to monitor for potential faults and to log quality-assurance data for service purposes; improved software to simplify daily calibration routines; customer-driven changes to the image presentation displays to allow faster, more flexible viewing; and, specifically for the international installed base, operator interface software that enables simplified translation into non-English languages.

"Our users are very pleased with the enhancements and with the support they have received from IMDS, and our distributors are similarly pleased that we have provided the resources to complete the upgrades and training. Some users, who had worried about technologically 'falling behind' the US PMA sites, are now quite content. We want them to be thrilled not only with the new optical molecular imaging capabilities but also with our support of their work," added Tim Hansen. "We are making steady progress in our US PMA study with these newer systems, and now we have a solid updated installed global base.